Jubilant Life Sciences witnessed a rise in share price on Friday after the company announced today that its subsidiary, Jubilant HollisterStier has been informed by the US Food and Drug Administration (USFDA) that its pharmaceutical sterile manufacturing facility in Spokane, Washington (USA) has been upgraded to the status of Voluntary Action Indicated (VAI).

Shares of the company are trading at Rs 172.65, up Rs 5.8, or 3.48% at the Bombay Stock Exchange (BSE) on Friday at 1:01 p.m.

The scrip has touched an intra-day high of Rs 176 and low of Rs 166.50. The total volume of shares traded at the BSE is 182,815.